Published in Kidney Int on March 01, 1994
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study | NCT00419770
Zygomycetes in human disease. Clin Microbiol Rev (2000) 9.80
Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev (2005) 5.77
Recent advances in the management of mucormycosis: from bench to bedside. Clin Infect Dis (2009) 3.77
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother (2011) 3.04
The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest (2007) 2.48
Pathogenesis of mucormycosis. Clin Infect Dis (2012) 2.14
Virulence factors of medically important fungi. Clin Microbiol Rev (1996) 1.83
Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother (2006) 1.40
Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis (2008) 1.38
Recent advances in the treatment of mucormycosis. Curr Infect Dis Rep (2010) 1.31
The high affinity iron permease is a key virulence factor required for Rhizopus oryzae pathogenesis. Mol Microbiol (2010) 1.27
Antifungal prophylaxis during neutropenia and immunodeficiency. Clin Microbiol Rev (1997) 1.16
Zygomycosis in Immunocompromised non-Haematological Patients. Mediterr J Hematol Infect Dis (2011) 1.13
Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis. Antimicrob Agents Chemother (2013) 0.91
Invasive mold infections: virulence and pathogenesis of mucorales. Int J Microbiol (2011) 0.88
Update on mucormycosis pathogenesis. Curr Opin Infect Dis (2013) 0.86
Necrotizing Soft Tissue Infections: Surgeon's Prospective. Int J Inflam (2013) 0.83
Human fungal pathogens of mucorales and entomophthorales. Cold Spring Harb Perspect Med (2014) 0.82
Mucormycosis of the intestine: a rare complication in Crohn's disease. Gastroenterol Hepatol (N Y) (2012) 0.81
Pulmonary invasive mucormycosis in a patient with secondary iron overload following deferoxamine therapy. Proc (Bayl Univ Med Cent) (2008) 0.79
Fob1 and Fob2 Proteins Are Virulence Determinants of Rhizopus oryzae via Facilitating Iron Uptake from Ferrioxamine. PLoS Pathog (2015) 0.79
Unravelling the Genome-Wide Contributions of Specific 2-Alkyl-4-Quinolones and PqsE to Quorum Sensing in Pseudomonas aeruginosa. PLoS Pathog (2016) 0.75
Diagnostic Dilemma in Appendiceal Mucormycosis: A Rare Case Report. Case Rep Surg (2016) 0.75
Host-iron assimilation: pathogenesis and novel therapies of mucormycosis. Mycoses (2014) 0.75
Molecular mechanisms of mucormycosis-The bitter and the sweet. PLoS Pathog (2017) 0.75
Reductive alkylation of ribosomes as a probe to the topography of ribosomal proteins. Biochem J (1974) 12.98
Iron transport and storage. Eur J Biochem (1987) 2.68
Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest (1993) 2.45
Fate of plasma membrane during endocytosis. II. Evidence for recycling (shuttle) of plasma membrane constituents. J Cell Biol (1979) 2.30
The preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem (1969) 2.28
The clinical pharmacokinetics of itraconazole: an overview. Mycoses (1989) 2.27
Ketoconazole -- a new broad spectrum orally active antimycotic. Experientia (1979) 2.24
Transferrin uptake by cultured rat embryo fibroblasts. The influence of temperature and incubation time, subcellular distribution and short-term kinetic studies. Eur J Biochem (1981) 2.23
Azole resistance in Candida albicans. J Med Vet Mycol (1986) 2.17
Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic. Eur J Obstet Gynecol Reprod Biol (1979) 2.01
Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother (1984) 1.83
Iron uptake by the yeast Saccharomyces cerevisiae: involvement of a reduction step. J Gen Microbiol (1987) 1.78
Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent. J Med Chem (1979) 1.78
Evidence for a continual exchange of 5'-nucleotidase between the cell surface and cytoplasmic membranes in cultured rat fibroblasts. Cell (1982) 1.69
The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother (1980) 1.68
Reductive methylation: a method for preparing functionally active radioactive ribosomes. FEBS Lett (1973) 1.67
Iron storage in Saccharomyces cerevisiae. FEBS Lett (1988) 1.67
Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis (1987) 1.64
Ribosomal proteins. XXIV. Trypsin digestion as a possible probe of the conformation of Escherichia coli ribosomes. Mol Gen Genet (1972) 1.60
Fate of plasma membrane during endocytosis. I. Uptake and processing of anti-plasma membrane and control immunoglobulins by cultured fibroblasts. J Cell Biol (1979) 1.59
The subunit structure of apoferritin and other eicosamers. Biochem J (1972) 1.58
Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. Postgrad Med J (1979) 1.47
The subunit structure of horse spleen apoferritin. I. The molecular weight of the subunit. J Biol Chem (1971) 1.42
Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol (1994) 1.35
Transferrin uptake by cultured rat embryo fibroblasts. The influence of lysosomotropic agents, iron chelators and colchicine on the uptake of iron and transferrin. Eur J Biochem (1982) 1.35
Receptor-mediated endocytosis of polymeric IgA and galactosylated serum albumin in rat liver. Evidence for intracellular ligand sorting and identification of distinct endosomal compartments. Eur J Biochem (1985) 1.28
Ferritin: structure, synthesis and function. N Engl J Med (1971) 1.28
The catalytic activity of horse spleen apoferritin. Preliminary kinetic studies and the effect of chemical modification. Biochem J (1973) 1.27
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones. J Med Chem (1984) 1.27
Low angle neutron scattering of ferritin studied by contrast variation. J Mol Biol (1976) 1.24
Amino acid sequence of horse spleen apoferritin. FEBS Lett (1981) 1.23
Structure and function of ferritin. Angew Chem Int Ed Engl (1973) 1.23
Transferrin protein and iron uptake by cultured rat fibroblasts. FEBS Lett (1979) 1.23
The fate of the plasma membrane during endocytosis. Biochem Soc Trans (1977) 1.22
Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi. Int J Dermatol (1992) 1.20
Ketoconazole in experimental candidosis. Rev Infect Dis (1981) 1.19
Transferrin protein and iron uptake by isolated rat erythroblasts. FEBS Lett (1982) 1.19
[Hemoglobins. XV. On monomeric and dimeric insect hemoglobins (Chironomus thummi)]. Hoppe Seylers Z Physiol Chem (1968) 1.19
Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant (1993) 1.18
New low resolution model for 50S subunit of Escherichia coli ribosomes. Proc Natl Acad Sci U S A (1976) 1.18
Isolation and characterization of phytoferritin from pea (Pisum sativum) and Lentil (Lens esculenta). Biochem J (1978) 1.18
The pharmacokinetics of ketoconazole in severely immunocompromised patients. J Antimicrob Chemother (1982) 1.17
The antifungal activity of ketoconazole. Am J Med (1983) 1.15
Isolation and characterization of iron-binding proteins from rat intestinal mucosa. Eur J Biochem (1976) 1.13
The organ-specificity of ferritin in human and horse liver and spleen. Biochem J (1973) 1.12
Recycling of fibroblast plasma-membrane antigens internalized during endocytosis [proceedings]. Biochem Soc Trans (1977) 1.11
Chemistry for an essential biological process: the reduction of ferric iron. Biometals (2002) 1.09
Immunohistochemical identification of Penicillium marneffei by monoclonal antibody. Int J Dermatol (1992) 1.09
Cellular pharmacology of deferrioxamine B and derivatives in cultured rat hepatocytes in relation to iron mobilization. Biochem Pharmacol (1985) 1.08
Reductive mobilisation of ferritin iron. Eur J Biochem (1985) 1.07
Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int J Dermatol (1994) 1.07
Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal. J Med Chem (1983) 1.07
The interaction of miconazole and ketoconazole with lipids. Biochem Pharmacol (1982) 1.06
Mobilisation of iron from ferritin fractions of defined iron content by biological reductants. FEBS Lett (1975) 1.04
The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium. Mykosen (1981) 1.01
Experimental systemic dermatophytosis. J Invest Dermatol (1984) 1.01
The effect of deferoxamine on different zygomycetes. J Infect Dis (1994) 1.01
Isolation and characterisation of rat mucosal ferritin. FEBS Lett (1974) 1.00
Fibronectin adsorption or/and covalent grafting on chemically modified PEEK film surfaces. J Biomater Sci Polym Ed (1999) 1.00
Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis. J Am Acad Dermatol (1992) 1.00
Aluminium toxicity and iron homeostasis. J Inorg Biochem (2001) 0.99
Adhesion of mammalian cells to polymer surfaces: from physical chemistry of surfaces to selective adhesion on defined patterns. Biomaterials (1998) 0.99
Flow and shuttle of plasma membrane during endocytosis. Acta Biol Med Ger (1977) 0.99
Culture media for the study of the effects of azole derivatives on germ tube formation and hyphal growth of C. albicans. Mykosen (1986) 0.98
Design of an efficient medium for insect cell growth and recombinant protein production. In Vitro Cell Dev Biol Anim (2001) 0.98
Iron mobilization from ferritin by chelating agents. J Inorg Biochem (1980) 0.97
Fate of plasma membrane during endocytosis. III. Evidence for incomplete breakdown of immunoglobulin in lysosomes of cultured fibroblasts. J Cell Biol (1981) 0.96
Competitive adsorption of proteins: key of the relationship between substratum surface properties and adhesion of epithelial cells. Biomaterials (1999) 0.96
Studies on the structure of ferritin and apoferritin from horse spleen. II. Chymotrypsin, subtilisin, cathepsin D and pepsin digestion of ferritin and apoferritin. Biochim Biophys Acta (1971) 0.95
Subcellular localization of ferritin and iron taken up by rat hepatocytes. Biochem J (1989) 0.95
Plant protein hydrolysates support CHO-320 cells proliferation and recombinant IFN-gamma production in suspension and inside microcarriers in protein-free media. Cytotechnology (2004) 0.95
Receptor mediated endocytosis of hemoglobin-haptoglobin, galactosylated serum albumin and polymeric IgA by the liver. Acta Biol Med Ger (1982) 0.95
Adhesion and growth of CaCo2 cells on surface-modified PEEK substrata. J Biomater Sci Polym Ed (2000) 0.95
Studies on the structure of ferritin and apoferritin from horse spleen. I. Tryptic digestion of ferritin and apoferritin. Biochim Biophys Acta (1969) 0.94
Gel filtration of proteins and peptides in the presence of 6M guanidine hydrochloride. J Chromatogr (1971) 0.93
Iron-reductases in the yeast Saccharomyces cerevisiae. Biochim Biophys Acta (1990) 0.93
Shape of the 50S subunit of Escherichia coli ribosomes. Proc Natl Acad Sci U S A (1977) 0.91
Oral treatment with ketoconazole in systemic candidosis of guinea-pigs: microbiology, hematology and histopathology. Sabouraudia (1985) 0.91
Effect of chloroquine and methylamine on endocytosis of fluorescein-labelled controlled IgG and of anti-(plasma membrane) IgG by cultured fibroblasts. Eur J Biochem (1981) 0.90
Subunit interactions in horse spleen apoferritin. Dissociation by extremes of pH. Biochem J (1973) 0.90
Experimental cutaneous Candida albicans infection in guinea-pigs. Sabouraudia (1971) 0.89
The subunit structure of horse spleen apoferritin; the molecular weight of the oligomer and its stability to dissociation by dilution. Biochem J (1973) 0.88
Biochemical and biophysical investigations of the ferrocene-iron-loaded rat. An animal model of primary haemochromatosis. Eur J Biochem (1991) 0.88
Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1. AIDS (2001) 0.88
Binding, uptake and intracellular processing of polymeric rat immunoglobulin A by cultured rat hepatocytes. Eur J Biochem (1982) 0.88
Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies. Infect Immun (1995) 0.88
Identification of the nuclear transcription factor NFkappaB in rat after in vivo ethanol administration. FEBS Lett (1996) 0.87
Chemical modification as a probe of the topography and reactivity of horse-spleen apoferritin. Eur J Biochem (1976) 0.87
The in-vitro antifungal spectrum of itraconazole. Mycoses (1989) 0.87
Optical rotatory dispersion and circular dichroism studies on ferritin and apoferritin. Biochim Biophys Acta (1971) 0.87
Interactions between iron metabolism and oxygen activation. Ciba Found Symp (1979) 0.86
Experimental zygomycosis due to Rhizopus spp. infection by various routes in guinea-pigs, rats and mice. Mycoses (1988) 0.86